Search by Drug Name or NDC
NDC 49035-0433-06 Headache Relief 250; 250; 65 mg/1; mg/1; mg/1 Details
Headache Relief 250; 250; 65 mg/1; mg/1; mg/1
Headache Relief is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Wal-Mart Stores Inc. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
NDC | 49035-0433 |
---|---|
Product ID | 49035-433_0e81794f-1ea5-48b7-96d0-743416670a92 |
Associated GPIs | 64990003200350 |
GCN Sequence Number | 040186 |
GCN Sequence Number Description | aspirin/acetaminophen/caffeine TABLET 250-250-65 ORAL |
HIC3 | H3D |
HIC3 Description | ANALGESIC/ANTIPYRETICS, SALICYLATES |
GCN | 10414 |
HICL Sequence Number | 001807 |
HICL Sequence Number Description | ASPIRIN/ACETAMINOPHEN/CAFFEINE |
Brand/Generic | Generic |
Proprietary Name | Headache Relief |
Proprietary Name Suffix | Extra Strength |
Non-Proprietary Name | Acetaminophen, Aspirin and Caffeine |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, FILM COATED |
Route | ORAL |
Active Ingredient Strength | 250; 250; 65 |
Active Ingredient Units | mg/1; mg/1; mg/1 |
Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
Labeler Name | Wal-Mart Stores Inc |
Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH DRUG |
Application Number | M013 |
Listing Certified Through | 2024-12-31 |
Package
NDC 49035-0433-06 (49035043306)
NDC Package Code | 49035-433-06 |
---|---|
Billing NDC | 49035043306 |
Package | 2 BOTTLE, PLASTIC in 1 CARTON (49035-433-06) / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (49035-433-12) |
Marketing Start Date | 2008-03-13 |
NDC Exclude Flag | N |
Pricing Information | N/A |